Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Commonly occurring adverse birth outcomes and maternal depression: a longitudinal study.

Kingsbury AM, Plotnikova M, Najman JM.

Public Health. 2018 Feb;155:43-54. doi: 10.1016/j.puhe.2017.11.001. Epub 2018 Jan 4.

PMID:
29306622
2.

Improving Patient Flow on Adult Mental Health Units: A multimodal Study of Canberra Hospital's Acute Psychiatric Facilities.

Fenton K, Kingsbury A, Jayalath S.

Psychiatr Danub. 2017 Sep;29(Suppl 3):594-603.

PMID:
28953836
3.

Social adversity in pregnancy and trajectories of women's depressive symptoms: A longitudinal study.

Kingsbury AM, Plotnikova M, Clavarino A, Mamun A, Najman JM.

Women Birth. 2018 Feb;31(1):52-58. doi: 10.1016/j.wombi.2017.06.016. Epub 2017 Jul 12.

PMID:
28711396
4.

Does having a difficult child lead to poor maternal mental health?

Kingsbury AM, Clavarino A, Mamun A, Saiepour N, Najman JM.

Public Health. 2017 May;146:46-55. doi: 10.1016/j.puhe.2017.01.001. Epub 2017 Feb 7.

PMID:
28404474
5.

The use of intraosseous needles for injection of contrast media for computed tomographic angiography of the thoracic aorta.

Winkler M, Talley C, Woodward C, Kingsbury A, Appiah F, Elbelasi H, Landwher K, Li X, Fleischmann D.

J Cardiovasc Comput Tomogr. 2017 May - Jun;11(3):203-207. doi: 10.1016/j.jcct.2017.03.001. Epub 2017 Mar 16.

6.

How have the lives of pregnant women changed in the last 30 years?

Kingsbury AM, Gibbons K, McIntyre D, Tremellen A, Flenady V, Wilkinson S, Mamun A, Najman JM.

Women Birth. 2017 Aug;30(4):342-349. doi: 10.1016/j.wombi.2017.01.008. Epub 2017 Feb 9.

PMID:
28190777
7.

Women's frequency of alcohol consumption prior to pregnancy and at their pregnancy-booking visit 2001-2006: A cohort study.

Kingsbury AM, Hayatbakhsh R, Gibbons K, Flenady V, Najman JM.

Women Birth. 2015 Jun;28(2):160-5. doi: 10.1016/j.wombi.2014.11.005. Epub 2014 Dec 3.

PMID:
25487003
8.

Trajectories and predictors of women's depression following the birth of an infant to 21 years: a longitudinal study.

Kingsbury AM, Hayatbakhsh R, Mamun AM, Clavarino AM, Williams G, Najman JM.

Matern Child Health J. 2015 Apr;19(4):877-88. doi: 10.1007/s10995-014-1589-6.

PMID:
25081239
9.

Cannabis, the pregnant woman and her child: weeding out the myths.

Jaques SC, Kingsbury A, Henshcke P, Chomchai C, Clews S, Falconer J, Abdel-Latif ME, Feller JM, Oei JL.

J Perinatol. 2014 Jun;34(6):417-24. doi: 10.1038/jp.2013.180. Epub 2014 Jan 23. Review.

PMID:
24457255
10.

Alone is a crowd: social motivations, social withdrawal, and socioemotional functioning in later childhood.

Coplan RJ, Rose-Krasnor L, Weeks M, Kingsbury A, Kingsbury M, Bullock A.

Dev Psychol. 2013 May;49(5):861-75. doi: 10.1037/a0028861. Epub 2012 Jun 11.

PMID:
22686178
11.

Amphetamines, the pregnant woman and her children: a review.

Oei JL, Kingsbury A, Dhawan A, Burns L, Feller JM, Clews S, Falconer J, Abdel-Latif ME.

J Perinatol. 2012 Oct;32(10):737-47. doi: 10.1038/jp.2012.59. Epub 2012 May 31. Review.

PMID:
22652562
12.

Birth outcomes associated with cannabis use before and during pregnancy.

Hayatbakhsh MR, Flenady VJ, Gibbons KS, Kingsbury AM, Hurrion E, Mamun AA, Najman JM.

Pediatr Res. 2012 Feb;71(2):215-9. doi: 10.1038/pr.2011.25. Epub 2011 Dec 21.

PMID:
22258135
13.

LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study.

Sharma S, Bandopadhyay R, Lashley T, Renton AE, Kingsbury AE, Kumaran R, Kallis C, Vilariño-Güell C, O'Sullivan SS, Lees AJ, Revesz T, Wood NW, Holton JL.

Neuropathol Appl Neurobiol. 2011 Dec;37(7):777-90. doi: 10.1111/j.1365-2990.2011.01187.x.

PMID:
21696411
14.

Illicit drug use before and during pregnancy at a tertiary maternity hospital 2000-2006.

Hayatbakhsh MR, Kingsbury AM, Flenady V, Gilshenan KS, Hutchinson DM, Najman JM.

Drug Alcohol Rev. 2011 Mar;30(2):181-7. doi: 10.1111/j.1465-3362.2010.00214.x.

PMID:
21355910
15.

Brain stem pathology in Parkinson's disease: an evaluation of the Braak staging model.

Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ.

Mov Disord. 2010 Nov 15;25(15):2508-15. doi: 10.1002/mds.23305.

PMID:
20818670
16.

Hyposmia in progressive supranuclear palsy.

Silveira-Moriyama L, Hughes G, Church A, Ayling H, Williams DR, Petrie A, Holton J, Revesz T, Kingsbury A, Morris HR, Burn DJ, Lees AJ.

Mov Disord. 2010 Apr 15;25(5):570-7. doi: 10.1002/mds.22688.

PMID:
20209627
17.

The correlates and consequences of early appearing social anxiety in young children.

Weeks M, Coplan RJ, Kingsbury A.

J Anxiety Disord. 2009 Oct;23(7):965-72. doi: 10.1016/j.janxdis.2009.06.006. Epub 2009 Jun 21.

PMID:
19596545
18.

Regional differences in the severity of Lewy body pathology across the olfactory cortex.

Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, Poewe W, Maier H, Lees AJ, Revesz T.

Neurosci Lett. 2009 Apr 3;453(2):77-80. doi: 10.1016/j.neulet.2009.02.006. Epub 2009 Feb 10.

PMID:
19356597
19.

The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors.

Abuirmeileh A, Harkavyi A, Kingsbury A, Lever R, Whitton PS.

Eur J Pharmacol. 2009 Feb 14;604(1-3):45-50. doi: 10.1016/j.ejphar.2008.11.009. Epub 2008 Nov 13.

PMID:
19026631
20.

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, Bonifati V, Quinn NP, Abou-Sleiman P, Wood NW, Petrie A, Sampaio C, Ferreira JJ, Holton J, Revesz T, Lees AJ.

Neurology. 2008 Sep 23;71(13):1021-6. doi: 10.1212/01.wnl.0000326575.20829.45.

PMID:
18809839
21.

Protecting the public by steering the big storms.

Kingsbury A.

US News World Rep. 2008 Jun 23-30;144(18):20. No abstract available.

PMID:
18702198
22.

Figuring out who's who.

Kingsbury A.

US News World Rep. 2008 May 12;144(13):26. No abstract available.

PMID:
18655692
23.

The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide.

Abuirmeileh A, Harkavyi A, Kingsbury A, Lever R, Whitton PS.

J Neurol Sci. 2008 Aug 15;271(1-2):131-6. doi: 10.1016/j.jns.2008.04.016. Epub 2008 May 27.

PMID:
18508084
24.

Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease.

Harkavyi A, Abuirmeileh A, Lever R, Kingsbury AE, Biggs CS, Whitton PS.

J Neuroinflammation. 2008 May 21;5:19. doi: 10.1186/1742-2094-5-19.

25.

From combat to the campus. A new program helps recently wounded soldiers attend college.

Kingsbury A.

US News World Rep. 2007 Sep 24;143(10):71. No abstract available.

PMID:
17957866
26.

A gamble on substance.

Kingsbury A.

US News World Rep. 2007 Aug 6;143(4):10-1. No abstract available.

PMID:
17853579
27.

DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.

Kumaran R, Kingsbury A, Coulter I, Lashley T, Williams D, de Silva R, Mann D, Revesz T, Lees A, Bandopadhyay R.

Neurobiol Dis. 2007 Oct;28(1):122-32. Epub 2007 Jul 18.

PMID:
17719794
28.

The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease.

Abuirmeileh A, Lever R, Kingsbury AE, Lees AJ, Locke IC, Knight RA, Chowdrey HS, Biggs CS, Whitton PS.

Eur J Neurosci. 2007 Jul;26(2):417-23.

PMID:
17650114
29.

Toward a safer campus.

Kingsbury A, Brush S, Green EW, Schulte B.

US News World Rep. 2007 Apr 30;142(15):48-50, 52. No abstract available.

PMID:
17491477
30.

17 and all burned out.

Kingsbury A.

US News World Rep. 2006 Aug 7;141(5):16. No abstract available.

PMID:
17432423
31.

Striatal dopaminergic neurons are lost with Parkinson's disease progression.

Porritt MJ, Kingsbury AE, Hughes AJ, Howells DW.

Mov Disord. 2006 Dec;21(12):2208-11.

PMID:
17029264
32.

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR.

Neurobiol Dis. 2006 Aug;23(2):329-41. Epub 2006 Jun 5.

PMID:
16750377
33.

Melanized nigral neuronal numbers in Nigerian and British individuals.

Muthane UB, Chickabasaviah YT, Henderson J, Kingsbury AE, Kilford L, Shankar SK, Subbakrishna DK, Lees AJ.

Mov Disord. 2006 Aug;21(8):1239-41.

PMID:
16673400
34.

Development, characterisation and epitope mapping of novel monoclonal antibodies for DJ-1 (PARK7) protein.

Bandopadhyay R, Miller DW, Kingsbury AE, Jowett TP, Kaleem MM, Pittman AM, de Silva R, Cookson MR, Lees AJ.

Neurosci Lett. 2005 Aug 5;383(3):225-30. Epub 2005 Apr 25.

PMID:
15955416
35.

Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition.

Bandopadhyay R, Kingsbury AE, Muqit MM, Harvey K, Reid AR, Kilford L, Engelender S, Schlossmacher MG, Wood NW, Latchman DS, Harvey RJ, Lees AJ.

Neurobiol Dis. 2005 Nov;20(2):401-11.

PMID:
15894486
36.

Evidence of a breakdown of corticostriatal connections in Parkinson's disease.

Stephens B, Mueller AJ, Shering AF, Hood SH, Taggart P, Arbuthnott GW, Bell JE, Kilford L, Kingsbury AE, Daniel SE, Ingham CA.

Neuroscience. 2005;132(3):741-54.

PMID:
15837135
37.

Hard lessons.

Tolson J, Hallett V, Kingsbury A.

US News World Rep. 2005 Mar 7;138(8):30-6. No abstract available.

PMID:
15768528
38.

Elevated glial brain-derived neurotrophic factor in Parkinson's diseased nigra.

Knott C, Stern G, Kingsbury A, Welcher AA, Wilkin GP.

Parkinsonism Relat Disord. 2002 Jun;8(5):329-41.

PMID:
15177062
39.

Alteration in alpha-synuclein mRNA expression in Parkinson's disease.

Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ.

Mov Disord. 2004 Feb;19(2):162-70.

PMID:
14978671
40.

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.

Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA, Lees AJ.

Brain. 2004 Feb;127(Pt 2):420-30. Epub 2003 Dec 8.

PMID:
14662519
41.

Endothelin in the middle cerebral artery: a case of multiple system atrophy.

Mickey I, Kilford L, Kingsbury A, Loesch A.

Histochem J. 2002 Oct;34(10):469-77.

PMID:
12945729
42.

Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease.

Gibson GE, Kingsbury AE, Xu H, Lindsay JG, Daniel S, Foster OJ, Lees AJ, Blass JP.

Neurochem Int. 2003 Jul;43(2):129-35.

PMID:
12620281
43.

Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: an in situ hybridization study.

Kingsbury AE, Cooper M, Schapira AH, Foster OJ.

Ann Neurol. 2001 Aug;50(2):142-9.

PMID:
11506395
44.

Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson's disease.

Tong ZY, Kingsbury AE, Foster OJ.

Brain Res Mol Brain Res. 2000 Jun 23;79(1-2):45-54.

PMID:
10925142
45.
47.

Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex.

Chen CP, Alder JT, Bray L, Kingsbury AE, Francis PT, Foster OJ.

Ann N Y Acad Sci. 1998 Dec 15;861:288-9. No abstract available.

PMID:
9928295
48.

Transabdominal cerclage.

Kingsbury AC.

Aust N Z J Obstet Gynaecol. 1998 Nov;38(4):479. No abstract available.

PMID:
9890243
49.

Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease.

Eve DJ, Nisbet AP, Kingsbury AE, Hewson EL, Daniel SE, Lees AJ, Marsden CD, Foster OJ.

Brain Res Mol Brain Res. 1998 Dec 10;63(1):62-71.

PMID:
9838046
50.

DNA fragmentation in human substantia nigra: apoptosis or perimortem effect?

Kingsbury AE, Mardsen CD, Foster OJ.

Mov Disord. 1998 Nov;13(6):877-84.

PMID:
9827610

Supplemental Content

Loading ...
Support Center